Literature DB >> 947752

The purification and characterisation of the human-serum binding protein for the 25-hydroxycholecalciferol (transcalciferin). Identity with group-specific component.

R Bouillon, H Van Baelen, W Rombauts, P De Moor.   

Abstract

The binding protein for 25-hydroxyvitamin D3 has been isolated from human serum by monitoring the recovery of 3H-labeled 25-hydroxyvitamin D3. After a 500-fold purification a pure protein was obtained as judged from the constant specific activity (ratio of absorbance versus radioactivity) on agarose and DEAE-Sephadex chromatography and on the presence of a single band on both cellulose acetate and polyacrylamide gel electrophoresis. The molecular weight of the purified protein was measured by gel filtration on agarose (56000), Sephadex G-75 (58000) and dodecylsulfate-polyacrylamide gel electrophoresis (56000). On sucrose gradient ultracentrifugation a sedimentation coefficient of 4.1 S was found. The isoelectric point was 4.89 S on isoelectric focusing. The stability of the protein at 60 degrees C was enhanced by the presence of excess 25-hydroxyvitamin D3. On tandem crossed immunoelectrophoresis the purified binding protein was found to be identical to the one present in whole serum. The activity of the isolated protein was demonstrated by a Ka at 4 degrees C of 1.2 X 10(10) l-mol-1. A binding capacity of 0.8 binding site/molecule was measured on a Sephadex G-25 column. During immunological studies with this protein it became evident that the binding protein is identical with another serum protein known as group-specific component (Gc). In analogy to other serum binding proteins we propose to call this group-specific component/25-hydroxyvitamin-D3-binding protein transcalciferin.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 947752     DOI: 10.1111/j.1432-1033.1976.tb10518.x

Source DB:  PubMed          Journal:  Eur J Biochem        ISSN: 0014-2956


  24 in total

Review 1.  Current Controversies: Are Free Vitamin Metabolite Levels a More Accurate Assessment of Vitamin D Status than Total Levels?

Authors:  Daniel D Bikle; Sofie Malmstroem; Janice Schwartz
Journal:  Endocrinol Metab Clin North Am       Date:  2017-12       Impact factor: 4.741

2.  Albumin--vitamin D-binding protein haplotypes in Asian-Pacific populations.

Authors:  L Z Chen; S Easteal; P G Board; K M Summers; K K Bhatia; R L Kirk
Journal:  Hum Genet       Date:  1990-06       Impact factor: 4.132

3.  Parathyroid hormone secretion and 25-hydroxyvitamin D levels in primary osteoporosis.

Authors:  J Dequeker; R Bouillon
Journal:  Calcif Tissue Res       Date:  1977-05

4.  Transcalciferin in serum and cytosol.

Authors:  R Bouillon; H Van Baelen; P De Moor
Journal:  Calcif Tissue Res       Date:  1977-05

Review 5.  Ethnic variation in vitamin D-binding protein (GC): a review of isoelectric focusing studies in human populations.

Authors:  M I Kamboh; R E Ferrell
Journal:  Hum Genet       Date:  1986-04       Impact factor: 4.132

6.  Effects of vitamin D-binding protein on bone resorption stimulated by 1,25 dihydroxyvitamin D3.

Authors:  S Vargas; R Bouillon; H Van Baelen; L G Raisz
Journal:  Calcif Tissue Int       Date:  1990-09       Impact factor: 4.333

7.  [Vitamin D-binding protein in human plasma. Analysis of genetic variation].

Authors:  H Cleve
Journal:  Naturwissenschaften       Date:  1985-10

8.  The transport of vitamin D in the serum of primates.

Authors:  R Bouillon; H van Baelen; P de Moor
Journal:  Biochem J       Date:  1976-12-01       Impact factor: 3.857

9.  A monoclonal antibody against human vitamin-D-binding protein for the analysis of genetic variation in the group-specific component system (Gc).

Authors:  R Hoffmann; A Braun; H Cleve
Journal:  Hum Genet       Date:  1990-01       Impact factor: 4.132

10.  A general method for fractionation of plasma proteins. Dye-ligand affinity chromatography on immobilized Cibacron blue F3-GA.

Authors:  E Gianazza; P Arnaud
Journal:  Biochem J       Date:  1982-01-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.